Psychedelic Research Landscape
A field map for psychedelic law, clinical research, safety, and therapy access in 2026.
Start here
- Start with legal status if the question is access.
- Use guides for substance-specific FDA, safety, and evidence context.
- Use tools for provider, state-law, and treatment-path comparisons.
Core landscape pages
Substance-by-substance evidence, safety, legal status, and access pathways.
State-by-state psilocybin, DMT, MDMA, ketamine, and ibogaine law.
Current FDA, clinical-trial, company, and policy developments.
Structured datasets and source-backed field trackers.